Veraxa Biotech AG (VRXA) vs Whitehawk Therapeutics, Inc. (WHWK)

Veraxa Biotech AG VRXA 1.11 +0.91%
Whitehawk Therapeutics, Inc. WHWK 2.90 −4.61%

Veraxa Biotech AG and Whitehawk Therapeutics, Inc. are both Biotechnology companies. Veraxa Biotech AG and Whitehawk Therapeutics, Inc. are of similar size ($173.3M and $162.5M).

Metric	VRXA	WHWK	Biotechnology median
P/E	—	n/m	8.50
P/S	—	8.65	9.71
P/B	—	1.31	2.13
Price to free cash flow	—	n/m	20.82
EV/EBITDA	—	n/m	0.64
EV/Sales	—	1.85	9.21
Earnings yield	—	(38.62%)	(33.15%)
Free cash flow yield	—	(29.08%)	(25.50%)

Metric	VRXA	WHWK	Biotechnology median
Gross margin	—	88.72%	65.16%
Operating margin	—	0.00%	0.00%
Net margin	—	0.00%	0.00%
Free cash flow margin	—	0.00%	0.00%
Return on equity	—	(44.98%)	(56.36%)
Return on assets	—	(42.60%)	(48.04%)
Return on invested capital	—	0.00%	0.00%

Metric	VRXA	WHWK	Biotechnology median
Revenue growth (TTM)	—	16.51%	6.02%
EPS growth (last fiscal year)	—	86.02%	30.26%
Revenue growth, 5-year CAGR	—	(13.29%)	9.41%
Net income growth, 5-year CAGR	—	0.00%	0.00%

Metric	VRXA	WHWK	Biotechnology median
Debt to equity	—	0.00	0.00
Current ratio	—	17.38	4.72
Net debt to EBITDA	—	1.26	0.96

Metric	VRXA	WHWK	Biotechnology median
Dividend yield	—	—	0.09%
Payout ratio	—	—	—

Metric	VRXA	WHWK	Biotechnology median
Market cap	162.50m	173.31m	135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack